EBOS Group Limited (NZE:EBO)

Market Cap	5.21B -34.7%
Revenue (ttm)	13.24B -7.0%
Net Income	232.16M -20.8%
EPS	1.18 -22.9%
Shares Out	205.04M
PE Ratio	21.61
Forward PE	16.77
Dividend	1.28 (5.18%)
Ex-Dividend Date	Sep 4, 2025

Volume	239,873
Average Volume	197,906
Open	25.44
Previous Close	25.42
Day's Range	23.86 - 25.44
52-Week Range	23.26 - 41.98
Beta	0.21
RSI	39.40
Earnings Date	Feb 25, 2026

About EBOS Group

EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services. It also offers community based health care services and ...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1922
• Employees: 5,770
• Stock Exchange: New Zealand Stock Exchange
• Ticker Symbol: EBO

Financial Performance

In fiscal year 2025, EBOS Group's revenue was 12.27 billion, a decrease of -6.99% compared to the previous year's 13.19 billion. Earnings were 215.14 million, a decrease of -20.77%.

Financial numbers in AUD